Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

PFIZER INC.

PFIZER INC. is a federal contractor, registered under UEI S2FWJSYBNUD4. It has been awarded $19,455 in federal contracts. Primary work spans Unknown NAICS, Pet Care (except Veterinary) Services, and Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Health And Human Services and Department Of Homeland Security.

Contact Information

Registration and classification details

Registration

UEI Code

S2FWJSYBNUD4

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

11

All time

Active

0

Currently performing

Completed

11

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with PFIZER INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PFIZER INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PFIZER INC.'s top NAICS codes and agencies

NAICS: 325412
New
Federal
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America
Solicitation # 36E79726R0041
The Department of Veterans Affairs intends to award a firm-fixed requirements-type contract for Sodium Bicarbonate 84mg/mL Injection 50mL vials, with an estimated annual usage of 65,587 bottles. This procurement is restricted to suppliers with products manufactured in the United States in accordance with FAR 6.103-3 and will be issued in a commercial item format per FAR Part 12. The contract will support multiple agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year, with four pre-priced one-year option periods. Under NAICS code 325412, the solicitation requires offerors to provide a unique NDC number and the exact drug name as it appears on the label. Strict labeling standards apply: the contractor's unique NDC label must be the only label on the product, and labels cannot be affixed over existing ones; however, they must allow VA labels to adhere securely on top. While glass bottles are acceptable, all packaging must be compatible with automated dispensing units such as Opti-fill and Baxter ATC Canisters. The solicitation is expected to be issued on October 21, 2026, with a tentative closing date of November 18, 2026, and all communications and submissions must be handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

4 days ago

DEADLINE

in 1 day
View Details
NAICS: 325412
New
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Nac Pharmaceuticals (36E797)

POSTED

4 days ago

DEADLINE

in 11 days
View Details